Introduction

Molecular pathology is one of the linchpins of precision medicine. No longer can treatment decisions related to therapy selection be rendered solely on the basis of histopathological analyses, as genomic analyses of human cancers are resulting in the identification of the genetic determinants of tumourigenesis, cancer progression and therapy response.

The pathologists’ role in the implementation of molecular tests in diagnostic practice and the ability of pathology laboratories to perform these tests and communicate the results to oncologists are germane to the successful translation of scientific advancements into benefit to patients.

This course aims to provide a comprehensive overview of the state-of-the-art molecular pathology approaches and their application, and to discuss current genomics and molecular pathology of solid malignancies.

Target audience

This course will provide a discussion of current concepts in molecular pathology, molecular pathology methods and their application. It will be beneficial for practicing pathologists and oncologists, residents and fellows in pathology and oncology, and molecular biologists with an interest in molecular pathology and precision medicine.

Topics to be covered

• The role of the pathologist in precision medicine
• Massively parallel sequencing methods and data interpretation
• Gene expression regulation
• Plasma circulating cell-free DNA analysis
• Perspectives in molecular testing for clinical decision-making in oncology in Europe and USA
• The molecular pathology of immunotherapy response
• Molecular pathology of breast cancer and the usefulness of transcriptomic and genomic biomarkers in breast cancer pathology and oncology practice
• Novel findings in ovarian and endometrial cancers
• Targeted therapies in melanoma
• KIT and novel therapeutic targets in gastrointestinal stromal tumours
• Genomics of lung and colorectal cancers, and the use of genetic biomarkers for therapeutic decision-making
• Molecular classification of sarcomas and central nervous system tumours

Scientific Programme Committee: Leonor David, Richard Marais, Jorge Reis-Filho, Giorgio Stanta and Marc van de Vijver
 

The 8th EACR-OECI Joint Course: Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 04/06/2018-06/06/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

This conference has been certified compliant with the MedTech Europe Code of Ethical Business Practice 

Course Organisers

96% of participants from the 2017 edition of the course would recommend it to others

“An excellent and up-to-date course with fantastic speakers!”

"This was indeed a great course, one of the best in this field!"

Feedback from 2017 participants